This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fujimoto Brothers Co., Ltd., Fujimoto Co., Ltd.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Matsubara, JP (2002)
- Osaka, JP (2002 - 2003)
Company Filing History:
Years Active: 2002-2003
Title: The Innovative Mind of Hironori Ohde: Advancements in Therapeutic Agents for Diabetes
Introduction: Hironori Ohde, an esteemed inventor based in Osaka, Japan, has made significant contributions to the field of pharmacology with a focus on therapeutic agents for diabetes. With a total of three patents to his name, Ohde's work emphasizes the enhancement of neurotransmitter activity, which holds great potential for treating various neurological disorders.
Latest Patents: Among Ohde's most recent inventions is an innovative therapeutic agent designed specifically for diabetes management. His latest patent, titled "Optically Active Aminopentane Derivatives," introduces a novel optically pure compound, −1-(Benzofuran-2-yl)-2-propylaminopentane. This compound, characterized by the absence of the (+)-isomer, along with its pharmaceutically acceptable acid salt, exhibits remarkable catecholaminergic activity enhancement (CAE effect). This trait is crucial for releasing the neurotransmitter catecholamine, making these compounds promising candidates for psychotropic compositions, antidepressants, and treatments for neurological diseases like Parkinson's and Alzheimer's.
Career Highlights: Hironori Ohde has spent a significant part of his career working with respected companies, including Fujimoto Brothers Co., Ltd. and Fujimoto Co., Ltd. His endeavors in these organizations have paved the way for groundbreaking innovations and allowed him to explore various facets of pharmaceutical development.
Collaborations: Throughout his professional journey, Ohde has collaborated with talented individuals, notably Fumio Yoneda and Mayumi Watanabe. These partnerships have fostered an environment of creativity and shared expertise, contributing to the effectiveness and impact of his inventions.
Conclusion: Hironori Ohde's dedication to developing therapeutic agents showcases the potential of innovation in the pharmaceutical field. With three patents reflecting his remarkable contributions, Ohde's work not only targets diabetes treatment but also addresses broader neurological disorders. His continuous efforts stand as an inspiring beacon of how inventors can drive positive change through their innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile